About this trial
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women.
The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
Patient of a rheumatologist at Duke University Medical Center
Disqualifiers
Inability to travel to Duke for follow-up visits
Inability to speak English
Not able to provide informed consent
Trial population
Any patients with lupus.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.